High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

BACKGROUND: Malignant melanoma is the most lethal form of skin cancer with a variable clinical course even in patients with thin melanomas and localized disease. Despite increasing insights into melanoma biology, no prognostic biomarkers have yet been incorporated into clinical protocols. Reduced ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Nodin, Björn, Fridberg, Marie, Jonsson, Liv, Bergman, Julia, Uhlén, Mathias, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433373/
https://www.ncbi.nlm.nih.gov/pubmed/22805320
http://dx.doi.org/10.1186/1746-1596-7-82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433373/
https://www.ncbi.nlm.nih.gov/pubmed/22805320
http://dx.doi.org/10.1186/1746-1596-7-82

Ejemplares similares